The risk of cardiovascular events in metabolic dysfunction–associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study

Hepatology Communications · Published 2026-07-27 · DOI 10.1097/hc9.0000000000001013

Free full text

Authors (13)

Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Jeong Eun Song, Hyun Chin Cho, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee, Seung Up Kim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jeong, J., Hong, J., Kim, D., et al. (2026). The risk of cardiovascular events in metabolic dysfunction–associated steatotic liver disease according to fibrosis stage and diabetes status: A cohort study. Hepatology Communications. https://doi.org/10.1097/hc9.0000000000001013

Related articles

• CRISPLD2 protects against liver inflammation and fibrosis via GRP78 to repress HMGB1/TLR4 axis–mediated STING palmitoylation · Hepatology Communications · 2026 · Same journal
• Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm · Hepatology Communications · 2026 · Same journal
• Prospective validation of a real-time natural language processing pipeline for the extraction of elastography results from electronic health record data · Hepatology Communications · 2026 · Same journal
• Reply: High mortality at safety-net hospitals for patients with cirrhosis · Hepatology Communications · 2026 · Same journal
• Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH · Hepatology Communications · 2026 · Same journal
• Manufacturing and electrostatic surface optimization of CAR-T cells improve therapeutic efficacy in liver malignancies · Hepatology Communications · 2026 · Same journal
• IL15-mediated crosstalk between LSECs and CD8⁺ tissue-resident memory T cells drives alcohol-associated hepatitis · Hepatology Communications · 2026 · Same journal
• Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label study · Hepatology Communications · 2026 · Same journal
• Contemporary global epidemiology of cirrhosis · Hepatology Communications · 2026 · Same journal
• The role of ammonia in chronic liver disease · Hepatology Communications · 2026 · Same journal